MIX

1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE

MIX is found in 4 entries.

MIX as free ligands, exist in 4 entries. Examples include 2FUM 2KGP 4G0V

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
Identifiers 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
Formula C22 H28 N4 O6
Molecular Weight 444.481  g/mol
Type NON-POLYMER
Isomeric SMILES OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12
InChI InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2
InChIKey KKZJGLLVHKMTCM-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 60
Chiral Atom Count 0
Chiral Atoms n/a
Bond Count 62
Aromatic Bond Count 12
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB01204   (Stereoisomeric match)
Name Mitoxantrone
Groups
  • approved
  • investigational
Description An anthracenedione-derived antineoplastic agent. [PubChem]
Synonyms
  • 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
  • Mitoxantrona
  • Mitoxantrone
  • Mitoxantronum
Salts
  • 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
  • Mitoxantrona
  • Mitoxantrone
  • Mitoxantronum
Brand Names
  • Mitoxantrone
  • Mitoxantrone Hydrochloride
  • Mitoxantrone Injection
  • Mitoxantrone Injection USP
  • Novantrone
Affected Organism Humans and other mammals
Indication For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis
Pharmacology Mitoxantrone has been shown in vitro to inhibit B cell, T cell, and macrophage proliferation and impair antigen presentation, as well as the secretion of interferon gamma, TNFa, and IL-2.
Mechanism of action Mitoxantrone, a DNA-reactive agent that intercalates into deoxyribonucleic acid (DNA) through hydrogen bonding, causes crosslinks and strand breaks. Mitoxantrone also interferes with ribonucleic acid (RNA) and is a potent inhibitor of topoisomerase II, an enzyme responsible for uncoiling and repairing damaged DNA. It has a cytocidal effect on both proliferating and nonproliferating cultured human cells, suggesting lack of cell cycle phase specificity.
Route of administration intravenous
Categories
  • Antineoplastic Agents
  • Analgesics
  • Antineoplastic Agents (Anthracycline, Systemic)
ATC-Code L01DB07
AHFS-Code 10:00.00
CAS number 65271-80-9

Drug Targets

Name Sequence Search Pharmacological Action Actions
... yes intercalation
DNA topoisomerase 2-alpha MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTY... yes inhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682